Clearside Biomedical Inc (CLSD)’s stock has witnessed a price hike of 4.64% from the previous close with its current price standing at $0.63. Its current price is -96.33% under its 52-week high of $17.10 and 6.42% more than its 52-week low of $0.59. Based on the past 30-day period, the stock price is -86.48% below the high and +1.02% above the low.
The 200-day Simple moving average is often placed more emphasis on by traders because of daily price changes. Investors will use the SMA-200 in different situations in trading activity as a key indicator to determine their support and resistance levels, and at the moment, CLSD’s SMA-200 is $9.1022. Additionally, it is important to take into account CLSD stock ratios, including its price-to-sales ratio, which is 0.99 for the last tewlve months.
How does Clearside Biomedical Inc (CLSD) stock rate among analysts? Buy, sell, or hold?
The key to trading is to concentrate on the future rather than on the past. During uncertain times, it can be hard to make decisions. The analysts who understand how a market works are usually the most accurate at forecasting its future. Currently, there are 7 brokerage firms that recommend the stock as a Moderate Buy. The ratings are commonly aggregated into a single number between 1 and 5. Buy or strong buy is scored 5, outperform is scored 4, hold is scored 3, underperform is scored 2 and strong sell is 1. Using a scale of 1-5, the current average recommendation is 3.29 in simple terms.
Clearside Biomedical Inc (CLSD): Earnings History
If we examine Clearside Biomedical Inc’s recent earnings history, in the last quarter ended on 9/30/2025, it posted adjusted earnings per share of -$1.14, beating the consensus of -$0.6. In other words, it beat the consensus by -$0.54, resulting in a -90.00% surprise. In the 3 months period before the previous quarter which was closed on 9/30/2025, the stock recorded adjusted earnings per share of -$1.14 in contrast with the Outlook of -$0.6. That was a difference of -$0.54 and a surprise of -90.00%.
Clearside Biomedical Inc (CLSD): Earnings History
Most analysts expect public companies to report earnings and revenue in line with their projections, but sometimes these figures vary from what they actually expected. In the current quarter, the company had earnings predictions made by 1 different analysts, who are expecting earnings to fall in between the range of -0.75 and -0.75 with an average Earnings Estimate of -0.75 which is in contrast with the last year earnings estimate of -1.50 and also replicates 50.00% growth rate year over year.
Clearside Biomedical Inc (NASDAQ: CLSD) Ownership Details
I will give a breakdown of the key shareholders in Clearside Biomedical Inc (CLSD). Recent figures show that the company’s insiders hold 12.88% of shares. A total of 34 institutional investors hold shares in the company, making 13.68% of its stock and 15.70% of its float.
Sep 30, 2025, it was reported that the Company’s largest institutional holder is Vanguard Group Inc holding total of 221.97 shares that make 4.24% of the company’s total number of shares and are currently priced at 0.14 million.
The securities firm Carmignac Gestion holds 100.56 shares of CLSD, making it the second largest institutional shareholder. Taking this into account, the holding percentage comes to 1.92%, and the holding percentage of shares is valued at 61248.0.
An overview of Clearside Biomedical Inc’s technicals
In order to learn about trade movements and investor behavior, it is best to analyze the short, medium, and long term technical indicators along with the average volume of a stock. A 20-day average of the stock’s daily volume suggests Clearside Biomedical Inc (CLSD) traded 384,142 shares per day, with a moving average of $3.1465 and price change of -3.1042. With the moving average of $3.6683 and a price change of -3.0342, about 179,811 shares changed hands on average over the past 50 days. Finally, CLSD’s 100-day average volume is 281,490 shares, alongside a moving average of $5.2254 and a price change of -11.9162.
